Spyre Therapeutics, Inc. SYRE
- SPY003 — Ulcerative Colitis Phase 2
- SPY003 — Crohn's Disease Phase 2
- SPY130 — Ulcerative Colitis Phase 2
- SPY230 — Ulcerative Colitis Phase 2
IL-23 (1 companies · 4 programs)
Companies with an active program directed at IL-23.